RECENT ADVANCES IN HETEROCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS: A MEDICINAL CHEMISTRY PERSPECTIVE

Heterocyclic compounds constitute a cornerstone of modern medicinal chemistry due to their remarkable structural diversity,
synthetic versatility, and wide-ranging biological activities. The incorporation of heteroatoms such as nitrogen, oxygen, and
sulfur into cyclic frameworks significantly influences physicochemical properties, enabling improved binding affinity,
selectivity, and pharmacokinetic behavior. Over the past decade, substantial advances have been made in the design and
development of heterocyclic scaffolds as therapeutic agents targeting various diseases, including cancer, infectious disorders,
metabolic syndromes, and neurological conditions. Novel synthetic methodologies, such as multicomponent reactions, green
chemistry approaches, and microwave-assisted techniques, have facilitated the efficient generation of diverse heterocyclic
libraries. Furthermore, the integration of computational tools, including molecular docking, quantitative structure–activity
relationship (QSAR) modeling, and artificial intelligence, has accelerated lead identification and optimization processes.
Heterocyclic compounds also play a crucial role in modulating biological targets such as enzymes, receptors, and ion channels,
contributing to their therapeutic potential. Despite these advancements, challenges related to toxicity, drug resistance, and
scalability remain critical considerations in drug development. This review provides a comprehensive overview of recent
progress in heterocyclic medicinal chemistry, highlighting synthetic strategies, structure–activity relationships,
pharmacological applications, and emerging trends. The insights presented aim to support the rational design of novel
heterocyclic therapeutics with enhanced efficacy and safety profiles.